Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering

Biomaterials

Volumn 30, Issue 13, 2009, Pages 2571-2581

  Wenk, Esther ^a   Meinel, Anne J ^a   Wildy, Sarah ^a   Merkle, Hans P ^a   Meinel, Lorenz ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Controlled drug delivery; Insulin like growth factor I; Microparticles; Scaffold; Silk fibroin

Indexed keywords

CONTROLLED GROWTHS; FTIR; GROWTH FACTOR RELEASE; HYDROLYTIC DEGRADATIONS; INSULIN-LIKE GROWTH FACTOR I; MICRO POROUS; MICROPARTICLES; PLGA MICROPARTICLES; POLIES (LACTIDECO-GLYCOLIDE); PORE INTERCONNECTIVITY; POROGEN LEACHING; RELEASE KINETICS; SEM; SILK FIBROIN; SPATIOTEMPORAL CONTROLS; SUPERNATANTS; SUSTAINED RELEASE; TISSUE ENGINEERING APPLICATIONS;

BIOACTIVITY; CONTROLLED DRUG DELIVERY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; INSULIN; LEACHING; METHANOL; MOLECULAR WEIGHT; PEPTIDES; SILK; TISSUE ENGINEERING; WATER CONTENT; WATER TREATMENT; WATER VAPOR;

SCAFFOLDS;

METHANOL; POLYGLACTIN; RECOMBINANT SOMATOMEDIN C; SILK FIBROIN;

ARTICLE; BETA SHEET; CONTROLLED STUDY; DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; HYDROLYSIS; LEACHING; MOLECULAR WEIGHT; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SOLUBILITY; TISSUE ENGINEERING; WATER VAPOR;

ANIMALS; BOMBYX; CELL LINE; FIBROINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POLYGLYCOLIC ACID; POROSITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TISSUE ENGINEERING;

EID: 60849129103     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.12.073     Document Type: Article

References (59)

1. Gerstenfeld L.C., Cullinane D.M., Barnes G.L., Graves D.T., and Einhorn T.A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88 5 (2003) 873-884
2. Whitaker M.J., Quirk R.A., Howdle S.M., and Shakesheff K.M. Growth factor release from tissue engineering scaffolds. J Pharm Pharmacol 53 11 (2001) 1427-1437
3. Meinel L., Zoidis E., Zapf J., Hassa P., Hottiger M.O., Auer J.A., et al. Localized insulin-like growth factor I delivery to enhance new bone formation. Bone 33 4 (2003) 660-672
4. Schrier J.A., and DeLuca P.P. Porous bone morphogenetic protein-2 microspheres: polymer binding and in vitro release. AAPS PharmSciTech 2 3 (2001) E17
5. Woo B.H., Fink B.F., Page R., Schrier J.A., Jo Y.W., Jiang G., et al. Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Pharm Res 18 12 (2001) 1747-1753
6. Hock J.M., Centrella M., and Canalis E. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 122 1 (1988) 254-260
7. Schmidmaier G., Wildemann B., Gabelein T., Heeger J., Kandziora F., Haas N.P., et al. Synergistic effect of IGF-I and TGF-beta1 on fracture healing in rats: single versus combined application of IGF-I and TGF-beta1. Acta Orthop Scand 74 5 (2003) 604-610
8. Blumenfeld I., Srouji S., Lanir Y., Laufer D., and Livne E. Enhancement of bone defect healing in old rats by TGF-beta and IGF-1. Exp Gerontol 37 4 (2002) 553-565
9. Boudignon B.M., Bikle D.D., Kurimoto P., Elalieh H., Nishida S., Wang Y., et al. Insulin-like growth factor I stimulates recovery of bone lost after a period of skeletal unloading. J Appl Phys 103 1 (2007) 125-131
10. Rose F.R., Hou Q., and Oreffo R.O. Delivery systems for bone growth factors - the new players in skeletal regeneration. J Pharm Pharmacol 56 4 (2004) 415-427
11. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J., et al. Silk-based biomaterials. Biomaterials 24 3 (2003) 401-416
12. Horan R.L., Antle K., Collette A.L., Wang Y., Huang J., Moreau J.E., et al. In vitro degradation of silk fibroin. Biomaterials 26 17 (2005) 3385-3393
13. Meinel L., Hofmann S., Karageorgiou V., Kirker-Head C., McCool J., Gronowicz G., et al. The inflammatory responses to silk films in vitro and in vivo. Biomaterials 26 2 (2005) 147-155
14. Meinel L., Betz O., Fajardo R., Hofmann S., Nazarian A., Cory E., et al. Silk based biomaterials to heal critical sized femur defects. Bone 39 4 (2006) 922-931
15. Hofmann S., Knecht S., Langer R., Kaplan D.L., Vunjak-Novakovic G., Merkle H.P., et al. Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng 10 (2006) 2729-2738
16. Kirker-Head C., Karageorgiou V., Hofmann S., Fajardo R., Betz O., Merkle H.P., et al. BMP-silk composite matrices heal critically sized femoral defects. Bone 41 2 (2007) 247-255
17. Altman G.H., Horan R.L., Lu H.H., Moreau J., Martin I., Richmond J.C., et al. Silk matrix for tissue engineered anterior cruciate ligaments. Biomaterials 23 20 (2002) 4131-4141
18. Uebersax L., Merkle H.P., and Meinel L. Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release 127 1 (2008) 12-21
19. Uludag H., D'Augusta D., Golden J., Li J., Timony G., Riedel R., et al. Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: a correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. J Biomed Mater Res 50 2 (2000) 227-238
20. Wei G., Jin Q., Giannobile W.V., and Ma P.X. Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J Control Release 112 1 (2006) 103-110
21. Hedberg E.L., Tang A., Crowther R.S., Carney D.H., and Mikos A.G. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites. J Control Release 84 3 (2002) 137-150
22. Lee M., Chen T.T., Iruela-Arispe M.L., Wu B.M., and Dunn J.C. Modulation of protein delivery from modular polymer scaffolds. Biomaterials 28 10 (2007) 1862-1870
23. Ungaro F., Biondi M., d'Angelo I., Indolfi L., Quaglia F., Netti P.A., et al. Microsphere-integrated collagen scaffolds for tissue engineering: effect of microsphere formulation and scaffold properties on protein release kinetics. J Control Release 113 2 (2006) 128-136
24. Perets A., Baruch Y., Weisbuch F., Shoshany G., Neufeld G., and Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res 65 4 (2003) 489-497
25. Chen F.M., Zhao Y.M., Zhang R., Jin T., Sun H.H., Wu Z.F., et al. Periodontal regeneration using novel glycidyl methacrylated dextran (Dex-GMA)/gelatin scaffolds containing microspheres loaded with bone morphogenetic proteins. J Control Release 121 1-2 (2007) 81-90
26. Uebersax L., Hagenmuller H., Hofmann S., Gruenblatt E., Muller R., Vunjaknovakovic G., et al. Effect of scaffold design on bone morphology in vitro. Tissue Eng 12 12 (2006) 3417-3429
27. Meinel L., Illi O.E., Zapf J., Malfanti M., Peter Merkle H., and Gander B. Stabilizing insulin-like growth factor-I in poly(d,l-lactide-co-glycolide) microspheres. J Control Release 70 1-2 (2001) 193-202
28. Sofia S., McCarthy M.B., Gronowicz G., and Kaplan D.L. Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res 54 1 (2001) 139-148
29. Hino T., Tanimoto M., and Shimabayashi S. Change in secondary structure of silk fibroin during preparation of its microspheres by spray-drying and exposure to humid atmosphere. J Colloid Interface Sci 266 1 (2003) 68-73
30. Luginbuehl V., Wenk E., Koch A., Gander B., Merkle H.P., and Meinel L. Insulin-like growth factor I-releasing alginate-tricalciumphosphate composites for bone regeneration. Pharm Res 22 6 (2005) 940-950
31. Pollak M.N., Polychronakos C., and Richard M. Insulin-like growth factor I: a potent mitogen for human osteogenic sarcoma. J Natl Cancer Inst 82 4 (1990) 301-305
32. Lopaczynski W., Harris S., and Nissley P. Insulin-like growth factor-I (IGF-I) dependent phosphorylation of the IGF-I receptor in MG-63 cells. Regul Pept 48 1-2 (1993) 207-216
33. Gupta R.K., Chang A.C., Griffin P., Rivera R., Guo Y.Y., and Siber G.R. Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid. Vaccine 15 6-7 (1997) 672-678
34. Asakura T., Kuzuhara A., Tabeta R., and Saito H. Conformation characterization of Bombyx mori silk fibroin in the solid state by high-frequency 13C cross polarization-magic angle spinning NMR, X-ray diffraction, and infrared spectroscopy. Macromolecules 18 (1985) 1841-1845
35. Monti P., Freddi G., Bertoluzza A., Kasai N., and Tsukada M. Raman spectroscopic studies of silk fibroin from Bombyx mori. J Raman Spectrosc 29 (1998) 297-304
36. Ishida M., Asakura T., Yokoi M., and Saito H. Solvent- and mechanical-treatment-induced conformational transition of silk fibroins studied by high-resolution solid-state 13C NMR spectroscopy. Macromolecules 23 (1990) 88-94
37. Marsh R.E., Corey R.B., and Pauling L. An investigation of the structure of silk fibroin. Biochim Biophys Acta 16 1 (1955) 1-34
38. Ma P.X. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 60 2 (2008) 184-198
39. Malafaya P.B., Silva G.A., Baran E.T., and Reis R.L. Drug delivery therapies I. General trends and its importance on bone tissue engineering applications. Curr Opin Solid State Mater Sci 6 (2002) 283-295
40. Karageorgiou V., Tomkins M., Fajardo R., Meinel L., Snyder B., Wade K., et al. Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res (2006) 324-334
41. Uebersax L., Mattotti M., Papaloizos M., Merkle H.P., Gander B., and Meinel L. Silk fibroin matrices for the controlled release of nerve growth factor (NGF). Biomaterials (2007) 4449-4460
42. Jin Q., Wei G., Lin Z., Sugai J.V., Lynch S.E., Ma P.X., et al. Nanofibrous scaffolds incorporating PDGF-BB microspheres induce chemokine expression and tissue neogenesis in vivo. PLoS ONE 3 3 (2008) e1729
43. Lee J.E., Kim S.E., Kwon I.C., Ahn H.J., Cho H., Lee S.H., et al. Effects of a chitosan scaffold containing TGF-beta1 encapsulated chitosan microspheres on in vitro chondrocyte culture. Artif Organs 28 9 (2004) 829-839
44. Deng T., Huang S., Zhou S., He L., and Jin Y. Cartilage regeneration using a novel gelatin-chondroitin-hyaluronan hybrid scaffold containing bFGF-impregnated microspheres. J Microencapsul 24 2 (2007) 163-174
45. Kim S.E., Park J.H., Cho Y.W., Chung H., Jeong S.Y., Lee E.B., et al. Porous chitosan scaffold containing microspheres loaded with transforming growth factor-beta1: implications for cartilage tissue engineering. J Control Release 91 3 (2003) 365-374
46. Defail A.J., Edington H.D., Matthews S., Lee W.C., and Marra K.G. Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds. J Biomed Mater Res 79 4 (2006) 954-962
47. DeFail A.J., Chu C.R., Izzo N., and Marra K.G. Controlled release of bioactive TGF-beta 1 from microspheres embedded within biodegradable hydrogels. Biomaterials 27 8 (2006) 1579-1585
48. Hu Y., Hollinger J.O., and Marra K.G. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds. J Drug Target 9 6 (2001) 431-438
49. Wenk E., Wandrey A.J., Merkle H.P., and Meinel L. Silk fibroin spheres as a platform for controlled drug delivery. J Control Release 132 1 (2008) 26-34
50. Rössle M., Panine P., Urban V.S., and Riekel C. Structural evolution of regenerated silk fibroin under shear: combined wide- and small-angle x-ray scattering experiments using synchrotron radiation. Biopolymers 74 4 (2004) 316-327
51. Min B.M., Jeong L., Lee K.Y., and Park W.H. Regenerated silk fibroin nanofibers: water vapor-induced structural changes and their effects on the behavior of normal human cells. Macromol Biosci 6 4 (2006) 285-292
52. Karageorgiou V., and Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26 27 (2005) 5474-5491
53. Zilberman M., and Grinberg O. HRP-loaded bioresorbable microspheres: effect of copolymer composition and molecular weight on microstructure and release profile. J Biomater Appl 22 5 (2008) 391-407
54. Hofmann S., Foo C.T., Rossetti F., Textor M., Vunjak-Novakovic G., Kaplan D.L., et al. Silk fibroin as an organic polymer for controlled drug delivery. J Control Release 111 1-2 (2006) 219-227
55. Wang X., Wenk E., Hu X., Castro G.R., Meinel L., Wang X., et al. Silk coatings on PLGA and alginate microspheres for protein delivery. Biomaterials 28 28 (2007) 4161-4169
56. Blundell T.L., Bedarkar S., Rinderknecht E., and Humbel R.E. Insulin-like growth factor: a model for tertiary structure accounting for immunoreactivity and receptor binding. Proc Natl Acad Sci USA 75 1 (1978) 180-184
57. Zhou C.Z., Confalonieri F., Medina N., Zivanovic Y., Esnault C., Yang T., et al. Fine organization of Bombyx mori fibroin heavy chain gene. Nucleic Acids Res 28 12 (2000) 2413-2419
58. Foo C.W., Bini E., Hensman J., Knight D.P., Lewis R.V., and Kaplan D.L. Role of pH and charge on silk protein assembly in insects and spiders. Appl Phys A 82 (2006) 223-233
59. Macri L., Silverstein D., and Clark R.A. Growth factor binding to the pericellular matrix and its importance in tissue engineering. Adv Drug Deliv Rev 59 13 (2007) 1366-1381